BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23557267)

  • 1. Systems level immune response analysis and personalized medicine.
    Brodin P; Valentini D; Uhlin M; Mattsson J; Zumla A; Maeurer MJ
    Expert Rev Clin Immunol; 2013 Apr; 9(4):307-17. PubMed ID: 23557267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoinformatics and systems biology methods for personalized medicine.
    Yan Q
    Methods Mol Biol; 2010; 662():203-20. PubMed ID: 20824473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translational immunologic safety evaluation: a perspective.
    Descotes J
    J Immunotoxicol; 2013; 10(1):83-9. PubMed ID: 22967109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translational bioinformatics and systems biology approaches for personalized medicine.
    Yan Q
    Methods Mol Biol; 2010; 662():167-78. PubMed ID: 20824471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoinformatics: a brief review.
    Tomar N; De RK
    Methods Mol Biol; 2014; 1184():23-55. PubMed ID: 25048118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosurveillance and immunoediting--can the immune response be made more "immunodemocratic"?
    Mincheff M
    J BUON; 2009 Sep; 14 Suppl 1():S89-96. PubMed ID: 19785075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression analysis in biomarker research and early drug development using function tested reverse transcription quantitative real-time PCR assays.
    Lohmann S; Herold A; Bergauer T; Belousov A; Betzl G; Demario M; Dietrich M; Luistro L; Poignée-Heger M; Schostack K; Simcox M; Walch H; Yin X; Zhong H; Weisser M
    Methods; 2013 Jan; 59(1):10-9. PubMed ID: 22796720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wild immunology.
    Pedersen AB; Babayan SA
    Mol Ecol; 2011 Mar; 20(5):872-80. PubMed ID: 21324009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Future perspectives of personalized medicine in traditional Chinese medicine: a systems biology approach.
    Zhang A; Sun H; Wang P; Han Y; Wang X
    Complement Ther Med; 2012; 20(1-2):93-9. PubMed ID: 22305254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beware the Medical-Industrial Complex.
    Stevens CW; Glatstein E
    Oncologist; 1996; 1(4):IV-V. PubMed ID: 10388005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Each cell counts: Hematopoiesis and immunity research in the era of single cell genomics.
    Jaitin DA; Keren-Shaul H; Elefant N; Amit I
    Semin Immunol; 2015 Feb; 27(1):67-71. PubMed ID: 25727184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune monitoring of T-cell responses in cancer vaccine development.
    Keilholz U; Martus P; Scheibenbogen C
    Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2346s-2352s. PubMed ID: 16609057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meeting the challenges of measuring human immune regulation.
    Martino D; Allen K
    J Immunol Methods; 2015 Sep; 424():1-6. PubMed ID: 25956036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of psychoneuroimmunology in personalized and systems medicine.
    Yan Q
    Methods Mol Biol; 2012; 934():3-19. PubMed ID: 22933138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicine.
    Agusti A; Sobradillo P; Celli B
    Am J Respir Crit Care Med; 2011 May; 183(9):1129-37. PubMed ID: 21169466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Where are we in genomics?
    Hocquette JF
    J Physiol Pharmacol; 2005 Jun; 56 Suppl 3():37-70. PubMed ID: 16077195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Translational approach for pharmacogenomics and personalized medicine].
    Zhang W; Zhou HH
    Yao Xue Xue Bao; 2011 Jan; 46(1):1-5. PubMed ID: 21465801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing human biologicals in animal host resistance models.
    Burleson GR; Burleson FG
    J Immunotoxicol; 2008 Jan; 5(1):23-31. PubMed ID: 18382855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of immune systems from self/not self to danger to artificial immune systems (AIS).
    Cooper EL
    Phys Life Rev; 2010 Mar; 7(1):55-78. PubMed ID: 20374928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.